136 related articles for article (PubMed ID: 10654322)
1. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis.
Németh I; Túri S; Haszon I; Bereczki C
Pediatr Nephrol; 2000 Jan; 14(1):13-7. PubMed ID: 10654322
[TBL] [Abstract][Full Text] [Related]
2. The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.
Túri S; Németh I; Varga I; Bodrogi T; Matkovics B
Pediatr Nephrol; 1992 Nov; 6(6):536-41. PubMed ID: 1482641
[TBL] [Abstract][Full Text] [Related]
3. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
[TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment.
Nenov D; Paskalev D; Yankova T; Tchankova P
Artif Organs; 1995 May; 19(5):436-9. PubMed ID: 7625923
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E-bonded cellulose membrane, lipoperoxidation, and anemia in hemodialysis patients.
Triolo L; Malaguti M; Ansali F; Comunian MC; Arcangeloni O; Coppolino F; Marrocco F; Sicoli R; Biagini M
Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):185-91. PubMed ID: 12751839
[TBL] [Abstract][Full Text] [Related]
6. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration.
Herrera J; Nava M; Romero F; Rodríguez-Iturbe B
Am J Kidney Dis; 2001 Apr; 37(4):750-7. PubMed ID: 11273875
[TBL] [Abstract][Full Text] [Related]
7. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
Georgatzakou HT; Tzounakas VL; Kriebardis AG; Velentzas AD; Papageorgiou EG; Voulgaridou AI; Kokkalis AC; Antonelou MH; Papassideri IS
Eur J Haematol; 2017 Jun; 98(6):590-600. PubMed ID: 28295628
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis.
Roozbeh J; Shahriyari B; Akmali M; Vessal G; Pakfetrat M; Raees Jalali GA; Afshariani R; Hasheminasab M; Ghahramani N
Ren Fail; 2011; 33(2):118-23. PubMed ID: 21332331
[TBL] [Abstract][Full Text] [Related]
10. The influence of vitamin E supplementation on erythropoietin responsiveness in chronic hemodialysis patients with low levels of erythrocyte superoxide dismutase.
Rusu A; Rusu F; Zalutchi D; Muresan A; Gherman Caprioara M; Kacso I
Int Urol Nephrol; 2013 Apr; 45(2):495-501. PubMed ID: 22528588
[TBL] [Abstract][Full Text] [Related]
11. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
[TBL] [Abstract][Full Text] [Related]
12. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of renal anemia with recombinant human erythropoietin].
Burghard R; Gordjani N; Leititis JU
Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
[TBL] [Abstract][Full Text] [Related]
15. Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment.
Taccone-Galluci M; Lubrano R; Trapasso E; Clerico A; Latorre P; Meloni C; Morosetti M; Castello MA; Casciani CU
ASAIO J; 1994; 40(3):M663-6. PubMed ID: 8555597
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment.
Sachs G; Siems W; Grune T; Schmidt G; Gerber G; Zoellner K
Biomed Biochim Acta; 1990; 49(2-3):S123-4. PubMed ID: 2386496
[TBL] [Abstract][Full Text] [Related]
17. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: a preliminary characterization.
Buoncristiani U; Galli F; Rovidati S; Albertini MC; Campus G; Canestrari F
Nephron; 1997; 77(1):57-61. PubMed ID: 9380239
[TBL] [Abstract][Full Text] [Related]
18. Enhanced coagulation and fibrinolysis during treatment with recombinant human erythropoietin in patients undergoing chronic hemodialysis.
Tomura S; Nakamura Y; Tachibana K; Deguchi F; Ando R; Chida Y; Marumo F
Blood Purif; 1993; 11(6):370-7. PubMed ID: 8043258
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
20. Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis.
Lilien MR; Duran M; Quak JM; Frankhuisen JJ; Schröder CH
Pediatr Nephrol; 2000 Nov; 15(1-2):17-20. PubMed ID: 11095004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
